The Wall Street Journal reports that the attorneys general of several states are aggressively pursuing cases based on allegations of deceptive marketing against pharmaceutical giants such as Bristol-Myers Squibb, GlaxoSmithKline and Sanofi SA. For example, in February, the AGs in Kentucky and Maryland filed lawsuits against GSK in their state courts, alleging the company deceptively marketed the diabetes treatment, Avandia (rosiglitazone), by downplaying the fact that the drug has been linked to an increased risk for heart attacks and strokes. At present, at least five other state AGs, who opted out of the $90-million settlement GSK agreed to pay in 2012 to resolve claims made by 37 other states and the District of Columbia, are pursuing similar lawsuits over Avandia.
From the American Association for Justice news release.
